The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Annual Review of Nutrition
Francois R JornayvazGerald I Shulman

Abstract

The metabolic syndrome is a clustering of cardiovascular risk factors, including insulin resistance, abdominal obesity, dyslipidemia, and hypertension, and is associated with other comorbidities such as a proinflammatory state and nonalcoholic fatty liver disease (NAFLD). Its prevalence is high, especially among developed countries, and mainly reflects overnutrition and sedentary lifestyle. Moreover, the developing countries are not spared, as obesity and its related problems such as the metabolic syndrome are increasing quickly. We review the potential primary role of skeletal muscle insulin resistance in the pathophysiology of the metabolic syndrome, showing that in lean, young, insulin-resistant individuals, impaired muscle glucose transport and glycogen synthesis redirect energy derived from carbohydrate into hepatic de novo lipogenesis, promoting the development of atherogenic dyslipidemia and NAFLD. The demonstration of a link between skeletal muscle insulin resistance and the metabolic syndrome offers opportunities in targeting early defects in muscle insulin action in order to counteract the development of the disease and its related complications.

References

May 1, 1991·The Journal of Clinical Investigation·M K HellersteinC H Shackleton
Feb 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·L H Nilsson, E Hultman
Feb 1, 1971·Diabetologia·J Köbberling
Dec 1, 1965·The Journal of Clinical Investigation·D S Schalch, D M Kipnis
Jul 1, 1967·Acta Medica Scandinavica·J Bergström, E Hultman
Feb 14, 1995·Proceedings of the National Academy of Sciences of the United States of America·D L RothmanG I Shulman
Sep 1, 1993·The American Journal of Physiology·W R Taylor, R W Alexander
Jun 1, 1993·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R Gruetter
Jun 15, 1996·The Journal of Clinical Investigation·M RodenG I Shulman
Jan 1, 1996·The American Journal of Physiology·B IllekT E Machen
Mar 27, 1998·The New England Journal of Medicine·S E InzucchiG I Shulman
Mar 31, 1998·Diabetes·K F PetersenG I Shulman
Apr 8, 1998·Current Opinion in Genetics & Development·D R Alessi, P Cohen
Jun 10, 1998·Pharmacotherapy·N Sparano, T L Seaton
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·S CasesR V Farese
Jan 23, 1999·The Journal of Clinical Investigation·A DresnerG I Shulman
May 26, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·B Balkau, M A Charles
Feb 17, 2000·The Journal of Clinical Investigation·O GavrilovaM L Reitman
Mar 18, 2000·The Journal of Biological Chemistry·J K KimG I Shulman
Jul 21, 2000·The Journal of Clinical Investigation·G I Shulman
Aug 23, 2000·The Journal of Clinical Investigation·H N Ginsberg
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·J K KimG I Shulman
Aug 2, 2001·The Journal of Biological Chemistry·S CasesR V Farese
Nov 10, 2001·American Journal of Physiology. Endocrinology and Metabolism·R BergeronG I Shulman
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·B H GoodpasterD E Kelley
Feb 22, 2002·The New England Journal of Medicine·Elif Arioglu OralAbhimanyu Garg
Apr 17, 2002·The Journal of Clinical Investigation·Hubert C ChenRobert V Farese
May 8, 2002·The Journal of Clinical Investigation·Jay D HortonMichael S Brown

❮ Previous
Next ❯

Citations

Jun 25, 2013·Trends in Endocrinology and Metabolism : TEM·Daniella E Duque-Guimarães, Susan E Ozanne
Jun 27, 2013·European Journal of Clinical Nutrition·A PaoliK A Grimaldi
Aug 23, 2012·American Journal of Physiology. Endocrinology and Metabolism·Mark D PetersonCharles F Burant
Nov 29, 2012·The Journal of Clinical Investigation·David BradleySamuel Klein
May 30, 2012·Cell & Bioscience·Jen-Chywan WangCharles A Harris
Oct 20, 2011·Endocrinology·Iordanes KaragiannidesCharalabos Pothoulakis
Oct 3, 2013·International Journal of Molecular Sciences·Jun-Jie LiuZhi-Xian Li
Feb 18, 2011·International Journal of Medical Sciences·Harry G PreussNicholas V Perricone
Sep 18, 2012·International Journal of Epidemiology·Kristina M StanfieldDavid A Leon
Feb 9, 2016·Indian Journal of Cancer·J X ScottR Aruna
Jun 8, 2015·Clínica e investigación en arteriosclerosis : publicación oficial de la Sociedad Española de Arteriosclerosis·Alba BerlangaTeresa Auguet
Jul 12, 2011·Trends in Cardiovascular Medicine·Bee K TanHarpal S Randeva
Nov 16, 2010·Gastroenterology·Constance E Ruhl, James E Everhart
Mar 1, 2015·Molecular and Cellular Endocrinology·Mohamed Asrih, François R Jornayvaz
Aug 21, 2015·European Journal of Clinical Investigation·Scott M Grundy
Jul 30, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Kanji YamaguchiYoshito Itoh
Aug 6, 2013·Pediatric Blood & Cancer·Galit P RosenGabriel Q Shaibi
Jul 28, 2015·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·E SabathR M Buijs
Jun 13, 2015·BioMed Research International·Sheila Cristina L SanchesFernando Silva Ramalho
May 9, 2012·Cell Metabolism·François R Jornayvaz, Gerald I Shulman
Sep 20, 2011·Best Practice & Research. Clinical Endocrinology & Metabolism·Katherine RobinsonBala Venkatesh
Jan 10, 2012·The American Journal of Cardiology·Scott M GrundyWilliam L Haskell
Oct 11, 2017·Journal of Pediatric Gastroenterology and Nutrition·Saleh AminHossam Hodeib
Sep 25, 2017·Journal of Endocrinological Investigation·R A CondorelliS La Vignera
Oct 5, 2017·Genes·Sophie A Montandon, François R Jornayvaz
Apr 20, 2011·Nature Reviews. Endocrinology·Michael P CzechGregory J Tesz
Dec 2, 2010·Nature Reviews. Gastroenterology & Hepatology·Lionel Hebbard, Jacob George
Dec 13, 2019·The Journal of Physiology·Carla Bruna PietrobonEgberto Gaspar de Moura
Jun 11, 2020·Journal of Developmental Origins of Health and Disease·Iala Milene BertassoPatricia Cristina Lisboa
Jan 1, 2013·ISRN Hepatology·Masashi NinomiyaTooru Shimosegawa

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
biopsy
transgenic
nuclear translocation

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.